What is TheraCIM
Epidermal growth factor receptor (EGFR) is a protein on the human cell that is important for normal and cancer cell division and growth. Theracim is an anti-cancer drug that can inhibit EGFR and stop the cancer cell from growing.
Theracim can only bind and block EGFR on the cancer cell and not on normal cell, make it less toxic compared to other anti-EGFR antibodies.
Learn how Theracim can benefit you
- Head and neck cancer that has spread to local tissue and lymph nodes
- Nasopharyngeal cancer that has spread to local tissue and lymph nodes
- Pancreatic cancer that has spread
- High grade glioma that has come back or spread